Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
124.38
-0.06 (-0.05%)
Nov 20, 2024, 4:00 PM EST - Market closed
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $7.43 billion as of November 21, 2024. Its market cap has increased by 40.04% in one year.
Market Cap
7.43B
Enterprise Value
7.61B
1-Year Change
40.04%
Ranking
Category
Stock Price
$124.38
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $7.43B, an increase of 1,556.19%. That is a compound annual growth rate of 33.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 7.14B | -1.73% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
| Jan 28, 2015 | 448.80M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemed | 8.21B |
| The Ensign Group | 8.11B |
| Bruker | 8.06B |
| Glaukos | 7.78B |
| Repligen | 7.59B |
| Legend Biotech | 7.43B |
| Jazz Pharmaceuticals | 7.17B |
| Walgreens Boots Alliance | 7.09B |